COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN-RELATED DISEASES AND PROMOTING DERMATOLOGICAL HEALTH

Abstract

The present disclosure relates to dietary supplements, for improving dermatological health. In embodiments, the composition is comprised of D-Biotin, grape seed extract, superoxide dismutase, zinc, Vitamin C, Lactobacillus Plantarum, Lactobacillus Reuteri, Lactobacillus Rhamnosus, or combinations/sub-combinations thereof.

Claims

1. A method for treating a skin-related condition by administering an effective amount of a composition to a patient, wherein the composition comprises: between about 1,000 mcg and about 3,000 mcg of D-Biotin; between about 50 mg and about 300 mg of a first blend, comprising: grape seed extract; superoxide dismutase; Zinc; and Vitamin C; between 1 Billion CFU/g and 5 Billion CFU/g of a second blend, comprising: Lactobacillus Plantarum; Lactobacillus Reuteri; and Lactobacillus Rhamnosus.

2. The method of claim 1, wherein the composition is administered orally in the form of a capsule.

3. The method of claim 1, wherein the first blend of grape seed extract, superoxide dismutase, Zinc and Vitamin C comprises about 150 mg of the composition administered to the patient.

4. The method of claim 1, wherein the grape seed extract in the first blend is a French grape seed extract.

5. The method of claim 1, wherein the superoxide dismutase in the first blend if derived from melon.

6. The method of claim 1, wherein the second blend of Lactobacillus Plantarum, Lactobacillus Reuteri and Lactobacillus Rhamnosus comprises about 3 Billion CFU/g of the composition administered to the patient.

7. The method of claim 1, wherein the D-Biotin comprises about 2,000 mcg of the composition administered to the patient.

8. The method of claim 1, wherein the composition administered to the patient does not comprise additives selected from the group consisting of gluten, wheat, egg, peanuts, tree nuts, dairy, sugar, com, soy, artificial colors, preservatives, fish and shellfish.

9. The method of claim 1, wherein the composition administered to the patient further comprises at least one palatability agent.

10. The method of claim 9, wherein the palatability agent is selected from the group consisting of plant oils, plant hydrolysates, yeast, and yeast hydrolysates.

11. A method for treating a skin-related disease, comprising: administering an effective amount of a composition to a patient, wherein the composition comprises: about 2,000 mcg of D-Biotin; about 150 mg of a first blend, wherein the first blend comprises: grape seed extract; superoxide dismutase; Zinc; and Vitamin C; about 3 Billion CFU/g of a second blend, wherein the second blend comprises: Lactobacillus Plantarum; Lactobacillus Reuteri; and Lactobacillus Rhamnosus.

12. The method of claim 11, wherein the composition is administered orally in the form of a capsule, tablet, lozenge or powder.

13. The method of claim 11, wherein the grape seed extract in the first blend is a French grape seed extract.

14. The method of claim 11, wherein the superoxide dismutase in the first blend if derived from melon.

15. The method of claim 11, wherein the composition administered to the patient does not comprise additives selected from the group consisting of gluten, wheat, egg, peanuts, tree nuts, dairy, sugar, com, soy, artificial colors, preservatives, fish and shellfish.

16. The method of claim 11, wherein the composition administered to the patient further comprises at least one palatability agent.

17. The method of claim 16, wherein the palatability agent is selected from the group consisting of plant oils, plant hydrolysates, yeast, and yeast hydrolysates.

18. The method of claim 11, wherein the composition is administered orally to the patient between 1-4 times each day.

19. The method of claim 11, wherein the skin-related disease is selected from the group consisting of skin cancer, acne, eczema, psoriasis, rosacea, ichthyosis, vitiligo, hives, dermatitis, and seborrheic dermatitis.

Description

DETAILED DESCRIPTION

[0033] Although the following text sets forth a Detailed Description of numerous different embodiments, it should be understood that the legal scope of the description is defined by the words of the claims set forth at the end of this disclosure. The Detailed Description is to be construed as exemplary only, and does not describe every possible embodiment since describing every possible embodiment would be impractical, if not impossible. Numerous alternative embodiments could be implemented, using either current technology or technology developed after the filing date of this patent, which would be encompassed by the scope of the claims.

[0034] As used herein, references to “the present invention” or aspects thereof should be understood to mean certain embodiments of the present invention and should not necessarily be construed as limiting all embodiments to a particular description.

[0035] As used herein, the phrases “at least one”, “one or more”, and “and/or” are open-ended expressions that are both conjunctive and disjunctive in operation. For example, each of the expressions “at least one of A, B and C”, “at least one of A, B, or C”, “one or more of A, B, and C”, “one or more of A, B, or C” and “A, B, and/or C” means A alone, B alone, C alone, A and B together, A and C together, B and C together, or A, B and C together.

[0036] Unless otherwise indicated, all numbers expressing quantities, amounts, dimensions, conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about”.

[0037] The term “a” or “an” entity, as used herein, refers to one or more of that entity. As such, the terms “a” (or “an”), “one or more” and “at least one” can be used interchangeably herein.

[0038] The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Accordingly, the terms “including,” “comprising,” or “having” and variations thereof can be used interchangeably herein.

[0039] It shall be understood that the term “means” as used herein shall be given its broadest possible interpretation in accordance with 35 U.S.C. Section 112(f). Accordingly, a claim incorporating the term “means” shall cover all structures, materials, or acts set forth herein, and all of the equivalents thereof. Further, the structures, materials, or acts and the equivalents thereof shall include all those described in the summary of the invention, brief description of the drawings, detailed description, abstract, and claims themselves.

[0040] In varying embodiments described herein, the present invention relates to a compound that improves an individual's skin and/or treats skin-related diseases. Certain elements of the novel compounds and methods for formulating the same are described in varying levels of detail herein.

[0041] Composition:

[0042] In embodiments, the composition is comprised of the foregoing elements:

[0043] 1) D-Biotin;

[0044] 2) A first proprietary blend comprising: [0045] a) grape seed extract (preferably French grape seed extract); [0046] b) superoxide dismutase (preferably derived from melon); [0047] c) Zinc; and [0048] d) Vitamin C;

[0049] 3) A second proprietary blend comprising: [0050] a) Lactobacillus Plantarum; [0051] b) Lactobacillus Reuteri; and [0052] c) Lactobacillus Rhamnosus

[0053] Certain of these components are described in greater detail below.

[0054] D-Biotin

[0055] D-biotin has an important role in overall health of an individual. D-Biotin been shown to help the body convert food into energy. In addition, it can boost hair and nails and helps manage blood sugar levels, among other benefits. D-Biotin has also been shown to have a positive impact if taken during pregnancy.

[0056] In a preferred embodiment, the compound is comprised of a pre-determined amount of D-Biotin. In a most preferred embodiment, the compound is comprised of about 2,000 mcg of D-Biotin.

[0057] Vitamin C

[0058] Vitamin C, also known as ascorbic acid, is a water-soluble vitamin. In a most preferred embodiment, the compound is comprised of a pre-determined amount of vitamin C.

[0059] Vitamin C is a cofactor in at least eight enzymatic reactions, which through experimentation have been found to support healthy skin and provide anti-aging properties. These enzymatic reactions are important, and increasing evidence indicates vitamin C improves the absorption of minerals, most notably iron, in adults and children.

[0060] Furthermore, vitamin C is essential to wound healing and in the creation of skin, tendons, ligaments, and blood vessels and other regions of the human anatomy.

[0061] In a preferred embodiment, the composition comprises a first proprietary blend that is comprised of Vitamin C.

[0062] Zinc

[0063] In a preferred embodiment, the composition comprises a first proprietary blend that is comprised of Zinc. In a preferred embodiment, the Zinc is provided as Zinc Glycinate.

[0064] Absent Elements

[0065] In addition, the composition of a preferred embodiment is substantially free of the following common allergens: gluten, wheat, eggs, peanuts, tree nuts, dairy, sugar and fish/shellfish. The composition preferably does not contain artificial colors, flavors, or preservatives, and is free from magnesium stearate (a common lubricant used in the manufacture of pharmaceuticals and dietary supplements).

[0066] Additional Elements

[0067] In varying embodiments, the composition can further comprise variances, particularly with respect to encapsulation and/or powder formulations. The composition may be provided in the form of a capsule, and may made with Hypromellose (HPMC), Nu-RICE® and/or Nu-FLOW® ingredients.

[0068] According to certain embodiments, the compositions described herein can further be provided with one or more palatability agents. These palatability agents serve to add flavor to the composition so that an effective dosage is easier to be ingested. It is within the scope of the present invention that any safe, flavor enhancing palatability agent can be used in a composition of the present invention. Particularly suitable palatability agents for use in the composition of the present invention include, but are not limited to, plant oils, plant hydrolysates, yeast, yeast hydrolysates, and combinations thereof.

[0069] Methods

[0070] An aspect of the invention is a method to treat a patient experiencing skin disease, skin cancer, acne, eczema, psoriasis, rosacea, ichthyosis, vitiligo, hives, dermatitis, and seborrheic dermatitis, among other conditions, with a composition comprising a unique combination and blend of D-Biotin, grape seed extract (Preferably French grape seed extract), superoxide dismutase (preferably from melon), zinc, Vitamin C, Lactobacillus Plantarum, Lactobacillus Reuteri, Lactobacillus Rhamnosus, or combinations/sub-combinations thereof.

[0071] According to one embodiment, during the method the patient is treated by providing an effective amount of the composition. In certain embodiments, the composition can be taken by the patient daily, with no regard to meals or time of day ingested. In one such embodiment, the composition is administered daily to a patient in need thereof in the form of two capsules that are fit for human consumption.

[0072] According to another embodiment, a method to prepare a compound is disclosed. The components are mixed in a proprietary blend and may be provided in a delivery device, for example, in the form of a capsule, tablet, lozenge or powder.

[0073] While various embodiments of the present disclosure have been described in detail, it is apparent that modifications and alterations of those embodiments will occur to those skilled in the art. However, it is to be expressly understood that such modifications and alterations are within the scope and spirit of the present disclosure, as set forth in the following claims. Ranges have been discussed and used within the forgoing description. One of skill in the art will understand that any sub-range within the stated range would be suitable, as would any number within the broad range, without deviating from the spirit of the present invention.

[0074] The foregoing discussion of the disclosure has been presented for purposes of illustration and description. The foregoing is not intended to limit the disclosure to the form or forms disclosed herein. In the foregoing Detailed Description for example, various features of the disclosure are grouped together in one or more embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed disclosure requires more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed embodiment.